Relieve A Pain Lotion
FDA Label NDC 87198-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Relieve A Pain Llc for the product Relieve A Pain (NDC 87198-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, directions, other information, inactive ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Lidocaine HCL 4.0% w/w

Purpose

Topical Analgesic

Uses

For temporary relief of pain and itching.

Warnings

For external use only

Avoid contact with eyes

Do not use in large quantities, particularly over raw surfaces or blistered areas.

Discontinue use and consult a doctor if

• Condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.

Keep out of reach of children

• If the product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For adults and children 12 years or older: Apply to affected area not more than 3 to 4 times daily.

Children under 12 years of age: consult a physician.

Other Information

Protect this product from excessive heat and direct sun.

Inactive Ingredients

Arnica Montana Flower Extract, C13-14 Isoparaffin, Chondroitin Sulfate, Dimethyl Sulfone (MSM), Emu Oil, Ethylhexylglycerin, Glucosamine Sulfate, Glycerin, Isopropyl Palmitate, Laureth-7, Phenoxyethanol, Polyacrylamide, Propylene Glycol, Stearic Acid, Triethanolamine, Water

Product Label

Image Description (Image 001 Updated)

Image Description (Image 001 Updated)

Image Description (Image 002 Updated 1)

Image Description (Image 002 Updated 1)

* Please review the disclaimer below.